Pharmaceuticals

Zorbtive (Serostim) Market 2026 growth is fueled by rising HIV patient numbers, increasing demand for growth hormone therapies in HIV care.

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Zorbtive or serostim Market Over The 2026–2030 Period?

Historical growth can be attributed to a rise in the diagnosis of growth hormone deficiency, the broadening of HIV-associated wasting treatment protocols, enhanced recombinant hormone manufacturing processes, greater clinician awareness of anabolic therapies, and the accessibility of hospital-based hormone treatments.

Future expansion is anticipated, driven by the broader acceptance of personalized hormone therapies, a rising demand for treatments that enhance quality of life, the expanding reach of specialty pharmacy distribution, an increased emphasis on long-acting formulations, and growing regulatory support for rare disease treatments. Concurrently, major trends expected during this period include a wider application of recombinant growth hormone therapies, a heightened focus on treatments aimed at improving body composition, the growing adoption of long-term hormone replacement regimens, an expansion of prescriptions tailored to specific indications, and enhanced monitoring of therapy outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20364&type=smp

What Underlying Factors Are Accelerating The Growth Of The Zorbtive or serostim Market?

The zorbtive or serostim market is anticipated to expand due to an increase in the number of patients with HIV going forward. Human immunodeficiency virus (HIV) is a virus that compromises the immune system by targeting and destroying CD4 cells, which are vital for defending the body against infections. The increasing occurrence of Human Immunodeficiency Virus (HIV) can be attributed to factors such as more unprotected sexual activity, limited access to preventative healthcare, insufficient awareness and education, and difficulties in HIV testing and treatment, especially among certain high-risk populations. Zorbtive or serostim assists individuals with human immunodeficiency virus (HIV) by addressing HIV-associated wasting syndrome, promoting weight gain, increasing lean body mass, and improving overall physical function and quality of life for patients with immune systems weakened by the virus. For instance, in October 2024, according to Health Security Agency (UKHSA), a US-based government agency, the number of newly diagnosed HIV cases in England rose by 15%, increasing from 2,451 in 2022 to 2,810 in 2023. Consequently, an increase in the number of patients with HIV is driving the growth of the zorbtive or serostim market.

How Is The Zorbtive or serostim Market Segmented Across Key Categories?

The zorbtive or serostim market covered in this report is segmented –

1) By Indication: Short Bowel Syndrome, HIV-Associated Wasting

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Adult Patients, Geriatric Patients

Who Are The Dominant Players Shaping The Zorbtive or serostim Market Landscape?

Major companies operating in the zorbtive or serostim market are EMD Serono Inc.

Read the full zorbtive or serostim market report here:

https://www.thebusinessresearchcompany.com/report/zorbtive-or-serostim-global-market-report

Which Region Is Projected To Dominate The Zorbtive or serostim Market During The Forecast Period?

North America was the largest region in the zorbtive or serostim market in 2025. The regions covered in the zorbtive or serostim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Zorbtive or serostim Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20364&type=smp

Browse Through More Reports Similar to the Global Zorbtive or serostim Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795